Table 1.
Differentially methylated regions (tiles 100 CpGs) by logistic regression (p < 0.05) in each pair-wise comparison. From these tiles, DMTs with more than 10% methylation values differences were filtered.
| DMTs (100 CpG Tiles) | # Tiles (% over Total Titles) Differentially Methylated, p < 0.05 | # Tiles Differentially Methylated with > 10% Methylation dif (% over DMTs) |
||
|---|---|---|---|---|
| INVIVO vs. BSA | 68,386 (25.13%) |
15,930 (23.29%) |
Up in INVIVO | 7,396 |
| Up in BSA | 8,534 | |||
| INVIVO vs. SERUM | 70,908 (26.06%) |
13,950 (19.67%) |
Up in INVIVO | 7,199 |
| Up in SERUM | 6,751 | |||
| INVIVO vs. FLUIDS | 88,359 (32.48%) |
20,588 (23.30%) |
Up in INVIVO | 9,796 |
| Up in FLUIDS | 10,792 | |||
| FLUIDS vs. BSA | 49,775 (18.30%) |
9,871 (19.83%) |
Up in FLUIDS | 5,893 |
| Up in BSA | 3,978 | |||
| FLUIDS vs. SERUM | 57,866 (21.27%) |
9,333 (16.13%) |
Up in FLUIDS | 5,364 |
| Up in SERUM | 3,969 | |||
| BSA vs. SERUM | 57,212 (21.03 %) |
8,652 (15.13 %) |
Up in BSA | 4,235 |
| Up in SERUM | 4,417 | |||